Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Purchase of 55,555 BRVE shares, $1000.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Braveheart Bio, Inc. (BRVE) | Purchase | 55,555 | $1000.0K |
| Jun 9, 2026 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 35,152 | n/a |
| Jun 3, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 11,050 | n/a |
| Apr 28, 2026 | Dyne Therapeutics, Inc. (DYN) | Gift | 53,625 | n/a |
| Apr 28, 2026 | Arcellx, Inc. (ACLX) | Tender of Shares | 21,659 | n/a |
| Jan 21, 2026 | Arcellx, Inc. (ACLX) | Exercise/Conversion | 6,000 | $37.7K |
| Jun 23, 2025 | GLYCOMIMETICS INC (CBIO) | Grant/Award | 9,023 | n/a |
| Jun 4, 2025 | Dyne Therapeutics, Inc. (DYN) | Grant/Award | 35,000 | n/a |
| May 30, 2025 | Arcellx, Inc. (ACLX) | Grant/Award | 9,174 | n/a |
| May 23, 2025 | Vor Biopharma Inc. (VOR) | Grant/Award | 30,000 | n/a |